Pharmacokinetics and Relative Bioavailability Study of Nevirapine in Healthy Volunteers
Xin Tian
Abstract
Xin Tian
Abstract
OBJECTIVE To evaluate relative bioavailability of domestic nevirapine in healthy volunteers.METHODS A single oral dose of 200 mg nevirapine domestic and imported tablets,was given to 20 health volunteers in a randomized cross-over study.The nevirapine concentrations in plasma were determined by HPLC method.RESULTS The concentrations of two formulations were fitted to an one-com- partment open model.The main pharmacokinetic parameters of two nevirapine tablets were as follows:t_(max)(3.50±1.05)and(4.20±1.24) h;ρ_(max) were(2 394±392)and(2170±434)μg·L~(-1);t_(1/2ka)(0.85±1.00)and(0.79±0.51)h;t_(1/2ke)(52.30±13.82)and(55.59±10.51)h;AUC_(0~t)(149.20±30.54)and(154.05±27.77)mg·h·L~(-1);AUC_(0~∞)(168.30±40.22)and(173.30±36.65)mg·h·L~(-1), respectiely.The relative bioavalability of F_(0~t) and F_(0~∞)(104.97±16.51)% and(105.21±18.93)%,respectively.CONCLUSION The ANOVA and two one-sided t test statistical analysis show that two formulations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To evaluate relative bioavailability of domestic nevirapine in healthy volunteers.METHODS A single oral dose of 200 mg nevirapine domestic and imported tablets,was given to 20 health volunteers in a randomized cross-over study.The nevirapine concentrations in plasma were determined by HPLC method.RESULTS The concentrations of two formulations were fitted to an one-com- partment open model.The main pharmacokinetic parameters of two nevirapine tablets were as follows:t_(max)(3.50±1.05)and(4.20±1.24) h;ρ_(max) were(2 394±392)and(2170±434)μg·L~(-1);t_(1/2ka)(0.85±1.00)and(0.79±0.51)h;t_(1/2ke)(52.30±13.82)and(55.59±10.51)h;AUC_(0~t)(149.20±30.54)and(154.05±27.77)mg·h·L~(-1);AUC_(0~∞)(168.30±40.22)and(173.30±36.65)mg·h·L~(-1), respectiely.The relative bioavalability of F_(0~t) and F_(0~∞)(104.97±16.51)% and(105.21±18.93)%,respectively.CONCLUSION The ANOVA and two one-sided t test statistical analysis show that two formulations are bioequivalent.
Key concepts: Nevirapine, Bioequivalence, Bioavailability, Pharmacokinetics, Pharmacology, Plasma concentration, Chemistry, Medicine